These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 16482646

  • 1. Comparison of 2 doses of etanercept (50 vs 100 mg) in active rheumatoid arthritis: a randomized double blind study.
    Johnsen AK, Schiff MH, Mease PJ, Moreland LW, Maier AL, Coblyn JS, Helfgott SM, Leff JA, Weinblatt ME.
    J Rheumatol; 2006 Apr; 33(4):659-64. PubMed ID: 16482646
    [Abstract] [Full Text] [Related]

  • 2. Once-weekly administration of 50 mg etanercept in patients with active rheumatoid arthritis: results of a multicenter, randomized, double-blind, placebo-controlled trial.
    Keystone EC, Schiff MH, Kremer JM, Kafka S, Lovy M, DeVries T, Burge DJ.
    Arthritis Rheum; 2004 Feb; 50(2):353-63. PubMed ID: 14872476
    [Abstract] [Full Text] [Related]

  • 3. Etanercept added to background methotrexate therapy in patients with rheumatoid arthritis: continued observations.
    Kremer JM, Weinblatt ME, Bankhurst AD, Bulpitt KJ, Fleischmann RM, Jackson CG, Atkins KM, Feng A, Burge DJ.
    Arthritis Rheum; 2003 Jun; 48(6):1493-9. PubMed ID: 12794815
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and safety of etanercept 50 mg twice a week in patients with rheumatoid arthritis who had a suboptimal response to etanercept 50 mg once a week: results of a multicenter, randomized, double-blind, active drug-controlled study.
    Weinblatt ME, Schiff MH, Ruderman EM, Bingham CO, Li J, Louie J, Furst DE.
    Arthritis Rheum; 2008 Jul; 58(7):1921-30. PubMed ID: 18576334
    [Abstract] [Full Text] [Related]

  • 5. A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate.
    Weinblatt ME, Kremer JM, Bankhurst AD, Bulpitt KJ, Fleischmann RM, Fox RI, Jackson CG, Lange M, Burge DJ.
    N Engl J Med; 1999 Jan 28; 340(4):253-9. PubMed ID: 9920948
    [Abstract] [Full Text] [Related]

  • 6. Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: a randomized, controlled trial.
    Davis JC, Van Der Heijde D, Braun J, Dougados M, Cush J, Clegg DO, Kivitz A, Fleischmann R, Inman R, Tsuji W, Enbrel Ankylosing Spondylitis Study Group.
    Arthritis Rheum; 2003 Nov 28; 48(11):3230-6. PubMed ID: 14613288
    [Abstract] [Full Text] [Related]

  • 7. A randomized, controlled study of a single intra-articular injection of etanercept or glucocorticosteroids in patients with rheumatoid arthritis.
    Bliddal H, Terslev L, Qvistgaard E, Konig M, Holm CC, Rogind H, Boesen M, Danneskiold-Samsøe B, Torp-Pedersen S.
    Scand J Rheumatol; 2006 Nov 28; 35(5):341-5. PubMed ID: 17062431
    [Abstract] [Full Text] [Related]

  • 8. Safety and efficacy of etanercept treatment in elderly subjects with rheumatoid arthritis.
    Bathon JM, Fleischmann RM, Van der Heijde D, Tesser JR, Peloso PM, Chon Y, White B.
    J Rheumatol; 2006 Feb 28; 33(2):234-43. PubMed ID: 16465653
    [Abstract] [Full Text] [Related]

  • 9. The safety and efficacy of adding etanercept to methotrexate or methotrexate to etanercept in moderately active rheumatoid arthritis patients previously treated with monotherapy.
    van der Heijde D, Burmester G, Melo-Gomes J, Codreanu C, Mola EM, Pedersen R, Freundlich B, Chang DJ, Etanercept Study 400 Investigators.
    Ann Rheum Dis; 2008 Feb 28; 67(2):182-8. PubMed ID: 17728331
    [Abstract] [Full Text] [Related]

  • 10. Etanercept in Sjögren's syndrome: a twelve-week randomized, double-blind, placebo-controlled pilot clinical trial.
    Sankar V, Brennan MT, Kok MR, Leakan RA, Smith JA, Manny J, Baum BJ, Pillemer SR.
    Arthritis Rheum; 2004 Jul 28; 50(7):2240-5. PubMed ID: 15248223
    [Abstract] [Full Text] [Related]

  • 11. Long-term safety and efficacy of 50 mg of etanercept twice weekly in patients with psoriasis.
    Tyring S, Gordon KB, Poulin Y, Langley RG, Gottlieb AB, Dunn M, Jahreis A.
    Arch Dermatol; 2007 Jun 28; 143(6):719-26. PubMed ID: 17576937
    [Abstract] [Full Text] [Related]

  • 12. C-reactive protein as a predictor of infliximab treatment outcome in patients with rheumatoid arthritis: defining subtypes of nonresponse and subsequent response to etanercept.
    Buch MH, Seto Y, Bingham SJ, Bejarano V, Bryer D, White J, Emery P.
    Arthritis Rheum; 2005 Jan 28; 52(1):42-8. PubMed ID: 15641046
    [Abstract] [Full Text] [Related]

  • 13. Patient reported outcomes in a trial of combination therapy with etanercept and methotrexate for rheumatoid arthritis: the TEMPO trial.
    van der Heijde D, Klareskog L, Singh A, Tornero J, Melo-Gomes J, Codreanu C, Pedersen R, Freundlich B, Fatenejad S.
    Ann Rheum Dis; 2006 Mar 28; 65(3):328-34. PubMed ID: 16079172
    [Abstract] [Full Text] [Related]

  • 14. Clinical outcomes of patients with rheumatoid arthritis after switching from infliximab to etanercept.
    Haraoui B, Keystone EC, Thorne JC, Pope JE, Chen I, Asare CG, Leff JA.
    J Rheumatol; 2004 Dec 28; 31(12):2356-9. PubMed ID: 15570634
    [Abstract] [Full Text] [Related]

  • 15. Unaltered etanercept pharmacokinetics with concurrent methotrexate in patients with rheumatoid arthritis.
    Zhou H, Mayer PR, Wajdula J, Fatenejad S.
    J Clin Pharmacol; 2004 Nov 28; 44(11):1235-43. PubMed ID: 15496641
    [Abstract] [Full Text] [Related]

  • 16. A placebo-controlled, randomized, double-blinded study evaluating the safety of etanercept in patients with rheumatoid arthritis and concomitant comorbid diseases.
    Weisman MH, Paulus HE, Burch FX, Kivitz AJ, Fierer J, Dunn M, Kerr DR, Tsuji W, Baumgartner SW.
    Rheumatology (Oxford); 2007 Jul 28; 46(7):1122-5. PubMed ID: 17470434
    [Abstract] [Full Text] [Related]

  • 17. Therapy of patients with rheumatoid arthritis: outcome of infliximab failures switched to etanercept.
    Buch MH, Bingham SJ, Bejarano V, Bryer D, White J, Reece R, Quinn M, Emery P.
    Arthritis Rheum; 2007 Apr 15; 57(3):448-53. PubMed ID: 17394231
    [Abstract] [Full Text] [Related]

  • 18. Combination therapy with etanercept and anakinra in the treatment of patients with rheumatoid arthritis who have been treated unsuccessfully with methotrexate.
    Genovese MC, Cohen S, Moreland L, Lium D, Robbins S, Newmark R, Bekker P, 20000223 Study Group.
    Arthritis Rheum; 2004 May 15; 50(5):1412-9. PubMed ID: 15146410
    [Abstract] [Full Text] [Related]

  • 19. Etanercept for the treatment of psoriasis: combination therapy with other modalities.
    Strober BE, Clarke S.
    J Drugs Dermatol; 2004 May 15; 3(3):270-2. PubMed ID: 15176161
    [Abstract] [Full Text] [Related]

  • 20. Community-based evaluation of etanercept in patients with rheumatoid arthritis.
    Farahani P, Levine M, Gaebel K, Wang EC, Khalidi N.
    J Rheumatol; 2006 Apr 15; 33(4):665-70. PubMed ID: 16568506
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.